FCGR2A and systemic lupus erythematosus: The combination of FcγR and the IgG Fc segment could stimulate immune cells to release inflammatory mediators, activate CD4+ and CD8+ T cells, and amplify humoral and cellular immunity, thereby promoting the pathogenesis of SLE (70).